Tag: ALS
Amyotrophic Lateral Sclerosis and Riluzole: How the First FDA-Approved Drug Slows ALS Progression
Riluzole is the first FDA-approved drug for ALS, modestly extending survival by 2-3 months. It works by reducing toxic glutamate activity in motor neurons. Despite side effects and limited efficacy, it remains the most prescribed ALS treatment worldwide.
